reac-technology
Contact us
reac-technology
Contact us

REAC Technology Launch: Free Autism Clinic Inaugurated in Brazil

Teresina, Brazil, inaugurates the ‘Professor Salvatore Rinaldi Clinic’ offering free REAC Technology treatments for children with Autism (ASD). Learn about this landmark social initiative.

  • December 5, 2025
Clínica-Batista-Teresina-REAC-Technology

Teresina (Brazil) Inaugurates the “Professor Salvatore Rinaldi Clinic”: REAC® Technology Offers Free Services for Neurodiversity.
A historic step for Brazilian public health recognizes the scientific and social value of REAC® Neuromodulation for Autism Spectrum Disorders (ASD).

The city of Teresina, capital of Piauí state in Brazil, celebrated a significant milestone in health and neurodiversity with the official inauguration of the “Professor Salvatore Rinaldi Clinic.”

This initiative, supported by local authorities, confers a prestigious honor upon Dr. Salvatore Rinaldi, founder of the Rinaldi Fontani Institute and pioneer of REAC® (Radio Electric Asymmetric Conveyer) Technology. The clinic was established with the crucial social mission of offering completely free services to children and students within the municipal network who are affected by Autism Spectrum Disorder (ASD) and other neurodevelopmental disorders.

REAC® Technology for Neurodiversity

The central and innovative element of the new center is the immediate integration of REAC® Technology into its treatment protocols. The BENE 110 device, provided to the clinic, enables precise and non-invasive neuromodulation, which has proven effective in supporting neurobiological self-regulation mechanisms.

Dr. Rinaldi, who participated in the device handover ceremony and will monitor the results remotely, emphasized that the use of REAC® in this context represents not only concrete support for families but also the launch of an important scientific and social research project.

“This center is not just a reference point for families in need in Teresina, but a model that we hope can be replicated throughout Brazil and beyond. It is a recognition of the value that Italian research, through REAC® Technology, can bring to the field of international public health,” stated Dr. Rinaldi.

The clinic’s inauguration and its dedication to Dr. Rinaldi confirm the growing global interest in therapeutic approaches that aim to optimize the body’s endogenous bioelectric activity for improved motor control and neurocognitive performance.

This news was widely reported by the local Brazilian press on December 4, 2025, including reference news portals such as Portal Clube News and Tribuna Piauí.

Did you find this article interesting? Share it!

Subscribe to the newsletter

reac-technology
Home About News
Contact us
© 2026 REAC® All rights reserved
Privacy Policy Terms of Use and Legal Notice
Manage Cookie

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V